Dalfampridine comment watch save
BreastfeedingPediatric

  • TRADE NAMES: Ampyra (Acorda); Fampyra
  • INDICATIONS: Multiple sclerosis (to improve walking)
  • SYNONYM: Fampridine; 4-aminopyridine; 4-AP
  • CLASS: Potassium channel blocker
  • HALF-LIFE: 5–6.5 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Trilaciclib

Contra-indicated in patients with a history of seizure, or with moderate or severe renal impairment.

Please login to view the rest of this drug profile.

Page last updated 12/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top